Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Astrocytosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
17
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Atrophic
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
10
|
1
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Autistic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
261
|
181
|
0.340 |
None |
1.000 |
1 |
|
2011 |
2019 |
Brain Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
60
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Cancer of Head
|
disease |
Neoplasms
|
Neoplastic Process
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cancer of Neck
|
disease |
Neoplasms
|
Neoplastic Process
|
25
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
130
|
172
|
0.350 |
None |
1.000 |
1 |
|
1999 |
2019 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
69
|
1
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Cerebral Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
60
|
2
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
CEROID LIPOFUSCINOSIS, NEURONAL, 6
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
42
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Child Development Deviations
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Child Development Disorders, Specific
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cholestasis, Extrahepatic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
32
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cocaine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
127
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
139
|
5
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2019 |
Cocaine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
289
|
7
|
0.350 |
None |
1.000 |
5 |
|
2001 |
2018 |
Developmental Disabilities
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
30
|
1
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Drug Withdrawal Symptoms
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Sign or Symptom
|
58
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
110
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Female infertility
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
28
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Female sterility
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
28
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Gliosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
17
|
3
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Head and Neck Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
33
|
11
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |